Designing a novel substrate for myogenic differentiation from induced pluripotent stem cells
Since their discovery, researchers have repeatedly demonstrated the potential medical applications of differentiated cells ...
Pharmaceutical Technology19d
Senju Pharmaceutical gets grant for treatment of retinal and nerve diseases with laminin and cells
The method involves administering either laminin 511 or its fragments along with nerve cells or retinal pigment epithelial cells to the subject. The conditions that can be treated using this method ...
Pharmaceutical Technology1mon
Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) drugs in development, 2023
The Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) drugs in development market research report provides comprehensive information on the therapeutics ...
PNAS17y
The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin α2-deficient congenital muscular dystrophy
We are grateful to the Nüsslein-Volhard laboratory (Max-Planck-Institut für Entwicklungsbiologie, Tübingen, Germany) for providing the mutant strains and to Julian Cocks and Cecelia Jenkin for fish ...